Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
100M
-
Number of holders
-
12
-
Total 13F shares, excl. options
-
120K
-
Shares change
-
+35K
-
Total reported value, excl. options
-
$103K
-
Value change
-
+$30.3K
-
Number of buys
-
9
-
Number of sells
-
-2
-
Price
-
$0.86
Significant Holders of PALISADE BIO, INC. - Common Stock, par value $0.01 per share (PALI) as of Q3 2025
13 filings reported holding PALI - PALISADE BIO, INC. - Common Stock, par value $0.01 per share as of Q3 2025.
PALISADE BIO, INC. - Common Stock, par value $0.01 per share (PALI) has 12 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 120K shares
of 100M outstanding shares and own 0.12% of the company stock.
Largest 10 shareholders include TWO SIGMA SECURITIES, LLC (29.4K shares), GEODE CAPITAL MANAGEMENT, LLC (26.6K shares), UBS Group AG (19.4K shares), XTX Topco Ltd (14.1K shares), Newbridge Financial Services Group, Inc. (13K shares), MORGAN STANLEY (8.62K shares), Tower Research Capital LLC (TRC) (5.4K shares), CITIGROUP INC (2.35K shares), Rockefeller Capital Management L.P. (500 shares), and Federation des caisses Desjardins du Quebec (100 shares).
This table shows the top 12 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.